Related Experiment Video
Updated: May 11, 2026

09:41
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
Published on: July 19, 2019
Improved MRI quantification of spinal cord atrophy in multiple sclerosis
Hugh Kearney1, Marios C Yiannakas, Khaled Abdel-Aziz
1NMR Research Unit, Queen Square MS Centre, UCL Institute of Neurology, London, UK.
Journal of Magnetic Resonance Imaging : JMRI
|May 2, 2013
Summary
The PSIR/ASM method offers superior reproducibility for measuring spinal cord cross-sectional area (CSA) in multiple sclerosis (MS) patients via MRI. This advanced technique enhances clinical trial efficiency for tracking cord atrophy.
Area of Science:
- Neuroimaging
- Neurology
- Medical Imaging Analysis
Background:
- Multiple sclerosis (MS) is a demyelinating disease affecting the central nervous system.
- Accurate measurement of spinal cord cross-sectional area (CSA) is crucial for monitoring MS progression and treatment efficacy.
- Existing MRI-based methods for CSA measurement have limitations in reproducibility.
Purpose of the Study:
- To identify an improved and highly reproducible method for measuring cervical spinal cord CSA using magnetic resonance imaging (MRI) in multiple sclerosis (MS).
- To compare the reproducibility of different MRI sequences and analysis techniques for spinal cord CSA measurement.
Main Methods:
- 15 controls and 15 MS patients underwent cervical cord MRI, with repeat scans at 6 months for reproducibility assessment.
- Two MRI sequences (3D PSIR and 3D MPRAGE) were used.
- Spinal cord CSA at C2-C3 was measured using semiautomated edge detection and active surface model (ASM) methods.
- Reproducibility was evaluated using coefficient of variation (COV) and intraclass correlation coefficient.
Main Results:
- The 3D PSIR sequence combined with the ASM analysis method demonstrated the lowest COV values for intrarater, interrater, and scan-rescan reproducibility (0.002%, 0.03%, 0.1%).
- No significant changes in spinal cord CSA were observed in controls at 6-month follow-up.
- A trend towards significant CSA changes was noted in MS patients over the 6-month period.
Conclusions:
- The PSIR/ASM combination is a more reproducible method for spinal cord CSA measurement in MS compared to established techniques.
- This improved reproducibility allows for reduced sample sizes in clinical trials.
- The method facilitates more efficient and reliable monitoring of longitudinal cord atrophy in MS clinical trials.

